Pouria Momayyezi

Huddinge, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19.

The HLA-B -21 M/T dimorphism associates with disease severity in COVID-19.

Journal: Genes and immunity

Published: July 04, 2024

Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness.

Emerging mutation in SARS-CoV-2 facilitates escape from NK cell recognition and associates with enhanced viral fitness.

Journal: PLoS pathogens

Published: March 05, 2024

Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells.

Genetic ablation of adhesion ligands averts rejection of allogeneic immune cells.

Journal: bioRxiv : the preprint server for biology

Published: October 24, 2023

Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies.

Genetic ablation of adhesion ligands mitigates rejection of allogeneic cellular immunotherapies.

Journal: Cell stem cell

Published: August 07, 2023

Viral escape from NK-cell-mediated immunosurveillance: A lesson for cancer immunotherapy?

Viral escape from NK-cell-mediated immunosurveillance: A lesson for cancer immunotherapy?

Journal: European journal of immunology

Published: April 30, 2023

Small Interfering RNA Delivery Into Primary Human Natural Killer Cells for Functional Gene Analyses.

Small Interfering RNA Delivery Into Primary Human Natural Killer Cells for Functional Gene Analyses.

Journal: Current protocols

Published: November 28, 2022

Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia.

Adaptive single-KIR+NKG2C+ NK cells expanded from select superdonors show potent missing-self reactivity and efficiently control HLA-mismatched acute myeloid leukemia.

Journal: Journal for immunotherapy of cancer

Published: September 24, 2022

An optimized platform for efficient siRNA delivery into human NK cells.

An optimized platform for efficient siRNA delivery into human NK cells.

Journal: European journal of immunology

Published: November 02, 2021

SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells.

SARS-CoV-2 Nsp13 encodes for an HLA-E-stabilizing peptide that abrogates inhibition of NKG2A-expressing NK cells.

Journal: Cell reports

Published: October 12, 2021

Showing 1-9 of 9

Last Updated: 09/26/2026